2010 was a very important year for Ferring as it marks the 60th anniversary of the company’s founding. Amongst the various commemorations this year and in…
In Conversation
You took over as GM back in 2008. No doubt that this was a challenging time to run a business, in particular in view of the…
The Dutch affiliate of Chiesi was established in 2007 when many changes were occurring in the local industry. The new healthcare system policy went into effect…
Interview with Marthin Kwakkelstein, Country Manager, Hungary, Estonia, Latvia, Lithuania, Celgene Hungary
The Hungarian pharmaceutical environment has been undergoing a turbulent time recently, with many new measures being implement by the Government. What are your observations, and how…
“Two traditions one vision” was the phrase used to describe the 2005 merger that formed Daiichi Sankyo as it is today. While referring specifically to a…
Assign Group started in 2002 as a small local CRO company founded in Austria; monitoring and doing minor project management only. Why was Austria chosen as…
Coincidentally, our meeting today comes two days after World Diabetes Day. How was this day commemorated in the Netherlands and how does it attest to the…
Within our reports we typically like to highlight the personalities of the industry and the stories behind the executives that we meet. As you are still…
Ten years of experience in the Dendrite group enabled you to cover a number of international positions, before its acquisition by Cegedim in May 2007. How…
In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and non-prescriptive drugs in…
Novo Nordisk is one of the very few pharmaceutical multinationals that has such a strong focus on one therapeutic area. Although the company is now diversifying,…
Interview with Riette Blacquiere, Executive Officer, The American Chamber of Commerce in the Netherlands
How do you operate in terms of the stakeholder management, with all of your associate members? Do you tend to operate from the committee perspective, or…